TXNRD1 and cancer: Therefore, an array of chemotherapeutics are known as inhibitors of TrxR1 and, moreover, due to its importance for cancer cell survival, TrxR1 is a promising target on its own for novel anticancer therapeutics [[31], [32], [33], [34], [35], [36], [37]].